China Clears HUTCHMED Drug for Two Autoimmune Blood Disorders
The NMPA approved SYVIK for certain adults with chronic primary ITP and warm antibody autoimmune hemolytic anemia.
Makkler Newsroom · Nov 19, 01:40 PM · 1 min read
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Profitability and valuation from the filed statements
Answers from price, statements, peer and news data. Not investment advice.
MakklerAI Q&A is open to MakklerPRO members. Upgrade to MakklerPRO